CLINICAL RESEARCH: CORONARY ARTERY DISEASE
Community-Based Provision of Statin and Aspirin After the Detection of Coronary Artery Calcium Within a Community-Based Screening Cohort
Allen J. Taylor, MD*, ,*,
Jody Bindeman, BSN*,
Irwin Feuerstein, MD*,,
Toan Le, ScD*,
Kelly Bauer, BSN*,
Carole Byrd, LVN*,
Holly Wu, MD* and
Patrick G. O’Malley, MD, MPH*,
* Departments of Medicine, Cardiology Service, Walter Reed Army Medical Center, Washington, DC
Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Manuscript received July 20, 2007;
revised manuscript received November 14, 2007,
accepted November 19, 2007.
* Reprint requests and correspondence: Dr. Allen J. Taylor, Chief, Cardiology Service, Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Building 2, Room 4A34, Washington, DC 20307-5001. (Email: allen.taylor{at}na.amedd.army.mil).
Objectives: We examined the association of coronary artery calcium (CAC) detected on a screening exam with subsequent statin and aspirin usage in a healthy male screening cohort.
Background: Whether the presence of CAC, an independent predictor of coronary heart disease outcomes, alters clinical management, such as the use of preventive medications, is unknown.
Methods: Men (n = 1,640) ages 40 to 50 years (mean 42 years) were screened for coronary heart disease risk factors and CAC. The CAC scores and risk factors were reported to patients, and results were made available in the electronic medical record; however, medications were not prescribed or recommended by the study. During up to 6 years of subsequent annual structured telephone follow-up, we observed the community-based initiation and persistence of aspirin and statin therapy.
Results: A progressive increase in the incidence of pharmacotherapy was noted over time such that those with CAC were 3 times more likely to receive a statin (48.5% vs. 15.5%, p < 0.001) and also significantly more likely to receive aspirin (53.0% vs. 32.3%; p < 0.001) than those without CAC. In multivariable models controlling for National Cholesterol Education Program risk variables and baseline medication use, CAC was strongly and independently associated with use of either statin (odds ratio [OR] 3.53; 95% confidence interval [CI] 2.66 to 4.69), aspirin (OR 3.05; 95% CI 2.30 to 4.05) or both (OR 6.97; 95% CI 4.81 to 10.10).
Conclusions: In this prospective cohort, the presence of coronary calcification was associated with an independent 3-fold greater likelihood of statin and aspirin usage.
|
Abbreviations and Acronyms
| | CAC = coronary artery calcium | | LDL-C = low-density lipoprotein cholesterol | | NCEP = National Cholesterol Education Program |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A33-A34.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
J. W. McEvoy, M. J. Blaha, K. Nasir, Y. E. Yoon, E.-K. Choi, I.-S. Cho, E.-J. Chun, S.-I. Choi, J. J. Rivera, R. S. Blumenthal, et al.
Impact of Coronary Computed Tomographic Angiography Results on Patient and Physician Behavior in a Low-Risk Population
Arch Intern Med,
July 25, 2011;
171(14):
1260 - 1268.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, et al.
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
December 21, 2010;
122(25):
e584 - e636.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, F. G. Kushner, et al.
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance
J. Am. Coll. Cardiol.,
December 14, 2010;
56(25):
e50 - e103.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. Shah
Screening Asymptomatic Subjects for Subclinical Atherosclerosis: Can We, Does It Matter, and Should We?
J. Am. Coll. Cardiol.,
July 6, 2010;
56(2):
98 - 105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nasir, R. L. McClelland, R. S. Blumenthal, D. C. Goff Jr, U. Hoffmann, B. M. Psaty, P. Greenland, R. A. Kronmal, and M. J. Budoff
Coronary Artery Calcium in Relation to Initiation and Continuation of Cardiovascular Preventive Medications: The Multi-Ethnic Study of Atherosclerosis (MESA)
Circ Cardiovasc Qual Outcomes,
May 1, 2010;
3(3):
228 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. Shah
The SHAPE Paradigm: A Commentary
Circ Cardiovasc Qual Outcomes,
January 1, 2010;
3(1):
106 - 109.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons and T. C. Gerber
Calcium Scoring With Computed Tomography: What Is the Radiation Risk?
Arch Intern Med,
July 13, 2009;
169(13):
1185 - 1187.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Budoff
Not all diabetics are created equal (in cardiovascular risk)
Eur. Heart J.,
September 2, 2008;
29(18):
2193 - 2194.
[Full Text]
[PDF]
|
|
|
|
